deafness hearing loss
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: * Adult (over 18 years old at the time of inclusion) * Post-lingually deafened (the subject had a good mastery of spoken language before onset of deafness) * Native Dutch speaker * Implanted, either unilaterally or bilaterally, with a Cochlear Implant manufactured by Cochlear Ltd (i.e., a Nucleus ® implant). * Implanted with one of the following implants: CI422, CI512, CI522, CI532, CI24R, CI24RE. * Implanted for at least 12 months.
Exclusion criteria
Exclusion criteria: A potential subject for the CI user group who meets any of the following criteria will be excluded from participation in this study: * Known abnormally formed cochlea * Known pre-implantation ossification of the cochlea * Severe cognitive disorders affecting their ability to understand spoken language * Intense facial nerve stimulation * Unaddressed electrode tip foldover * More than 4 electrodes deactivated because of malfunction (open/short circuit) or lack of response * Additional illnesses or handicaps that could impact the ability to participate in the study, at the clinician*s discretion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the level of improvement of phoneme and word recognition score on the individual scale after the interventions. | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary endpoints are: 1. the results of the exploratory analyses performed on the correlation between the spectrotemporal assessment test and the subjects* error profile. 2. the results of the exploratory analyses performed on the differences between error patterns in phoneme and word recognition tests, both between and within subjects. 3. The results of the SUS/IMI questionnaires concerning the individualized training app | — |
Countries
Netherlands